Tirdzniecība Oscar Health, Inc. - OSCR CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Starpība | 0.06 | ||||||||
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.024874% | ||||||||
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | 0.002651% | ||||||||
Nakts laika nodeva | 21:00 (UTC) | ||||||||
Min. tirgotais daudzums | 1 | ||||||||
Valūta | USD | ||||||||
Drošības rezerve | 20% | ||||||||
Fondu birža | United States of America | ||||||||
Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Iepriekš. aizvērt* | 6.38 |
Atvērt* | 6.3 |
Izmaiņas par 1 gadu* | -37.81% |
Dienas Diapazons* | 6.3 - 7 |
52 ned Diapazons | 2.05-10.53 |
Vidējais apjoms (10 dienas) | 8.37M |
Vidējais apjoms (3 mēneši) | 56.82M |
Tirgus Kapitalizācija | 1.21B |
Cenas/Peļņas Attiecība | -100.00K |
Izvietotās Akcijas | 216.30M |
Ieņēmumi | 3.96B |
EPS | -2.84 |
Dividende (Ienesīgums %) | N/A |
Beta | -100.00K |
Nākamās Peļņas Datums | May 9, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
---|---|---|---|---|---|---|
Mar 29, 2023 | 6.38 | 0.76 | 13.52% | 5.62 | 6.64 | 5.51 |
Mar 28, 2023 | 5.56 | 0.15 | 2.77% | 5.41 | 6.86 | 5.29 |
Mar 27, 2023 | 3.57 | 0.23 | 6.89% | 3.34 | 3.61 | 3.31 |
Mar 24, 2023 | 3.33 | -0.06 | -1.77% | 3.39 | 3.48 | 3.20 |
Mar 23, 2023 | 3.47 | -0.07 | -1.98% | 3.54 | 3.83 | 3.42 |
Mar 22, 2023 | 3.49 | -0.11 | -3.06% | 3.60 | 3.78 | 3.47 |
Mar 21, 2023 | 3.63 | 0.17 | 4.91% | 3.46 | 3.69 | 3.41 |
Mar 20, 2023 | 3.34 | 0.00 | 0.00% | 3.34 | 3.38 | 3.20 |
Mar 17, 2023 | 3.37 | -0.01 | -0.30% | 3.38 | 3.41 | 3.27 |
Mar 16, 2023 | 3.42 | 0.06 | 1.79% | 3.36 | 3.53 | 3.33 |
Mar 15, 2023 | 3.49 | -0.01 | -0.29% | 3.50 | 3.60 | 3.37 |
Mar 14, 2023 | 3.65 | -0.31 | -7.83% | 3.96 | 4.09 | 3.64 |
Mar 13, 2023 | 3.87 | 0.12 | 3.20% | 3.75 | 3.95 | 3.65 |
Mar 10, 2023 | 3.90 | -0.27 | -6.47% | 4.17 | 4.18 | 3.79 |
Mar 9, 2023 | 4.19 | -0.45 | -9.70% | 4.64 | 4.82 | 4.18 |
Mar 8, 2023 | 4.72 | 0.10 | 2.16% | 4.62 | 4.73 | 4.57 |
Mar 7, 2023 | 4.66 | 0.03 | 0.65% | 4.63 | 4.76 | 4.53 |
Mar 6, 2023 | 4.72 | -0.13 | -2.68% | 4.85 | 4.98 | 4.66 |
Mar 3, 2023 | 4.92 | 0.28 | 6.03% | 4.64 | 4.95 | 4.54 |
Mar 2, 2023 | 4.65 | -0.23 | -4.71% | 4.88 | 5.01 | 4.64 |
Oscar Health, Inc. Events
Laiks (UTC) (UTC) | Valsts | Notikums |
---|---|---|
No events scheduled |
- Ikgadējs
- Ceturkšņa
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Kopējie ienākumi | 3963.64 | 1838.71 | 462.801 | 488.188 |
Kopējie Darbības Izdevumi | 4553.5 | 2403.37 | 865.067 | 747.577 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 627.513 | 431.853 | 274.378 | 169.568 |
Depreciation / Amortization | 15.283 | 14.605 | 11.285 | 6.899 |
Darbības Izdevumi | -589.867 | -564.659 | -402.266 | -259.389 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -22.623 | -4.72 | -3.514 | 0 |
Neto Ienākumi Pirms Nodokļu Nomaksas | -610.075 | -570.58 | -405.78 | -259.389 |
Neto Ienākumi Pēc Nodokļu Nomaksas | -609.552 | -571.426 | -406.825 | -261.182 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | -606.275 | -572.606 | -406.825 | -261.182 |
Neto Ienākumi | -606.275 | -572.606 | -406.825 | -261.182 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -606.275 | -572.606 | -406.825 | -261.182 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -606.275 | -572.606 | -406.825 | -261.182 |
Atšķaidītie Neto Ienākumi | -606.275 | -572.606 | -406.825 | -261.182 |
Atšķaidītie Ienākumi par Akcijām | 212.475 | 178.967 | 197.037 | 197.037 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -2.8534 | -3.19951 | -2.06471 | -1.32554 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | |
Atšķaidītā Normalizētā Peļņa par Akciju | -2.8534 | -3.12295 | -2.23769 | -1.33856 |
Total Premiums Earned | 3871.12 | 1831.02 | 455.035 | 468.861 |
Net Investment Income | 93.795 | 7.483 | 6.527 | 18.846 |
Realized Gains (Losses) | -1.274 | 0.212 | 1.239 | 0.481 |
Losses, Benefits, and Adjustments, Total | 3910.71 | 1936.74 | 579.404 | 571.11 |
Neparedzēti Izdevumi (Ienākumi) | 0 | 20.178 | ||
Citi, Neto | 2.415 | -1.201 | ||
Mazākuma Interese | 3.277 | -1.18 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Kopējie ienākumi | 995.127 | 978.427 | 1017.32 | 972.765 | 496.067 |
Kopējie Darbības Izdevumi | 1217.61 | 1170.8 | 1123.81 | 1041.29 | 692.822 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 147.596 | 149.671 | 149.503 | 144.531 | 139.389 |
Neparedzēti Izdevumi (Ienākumi) | 0 | 0 | 0 | 0 | 0 |
Darbības Izdevumi | -222.479 | -192.372 | -106.487 | -68.529 | -196.755 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -6.135 | -6.126 | -6.141 | -4.221 | -0.397 |
Citi, Neto | 1.339 | 3.336 | 0.793 | -3.053 | -1.201 |
Neto Ienākumi Pirms Nodokļu Nomaksas | -227.275 | -195.162 | -111.835 | -75.803 | -198.353 |
Neto Ienākumi Pēc Nodokļu Nomaksas | -226.56 | -193.547 | -112.125 | -77.32 | -198.242 |
Mazākuma Interese | 0.514 | 0.634 | -0.039 | 2.168 | -1.18 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | -226.046 | -192.913 | -112.164 | -75.152 | -199.422 |
Neto Ienākumi | -226.046 | -192.913 | -112.164 | -75.152 | -199.422 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -226.046 | -192.913 | -112.164 | -75.152 | -199.422 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -226.046 | -192.913 | -112.164 | -75.152 | -199.422 |
Atšķaidītie Neto Ienākumi | -226.046 | -192.913 | -112.164 | -75.152 | -199.422 |
Atšķaidītie Ienākumi par Akcijām | 215.217 | 212.823 | 211.311 | 210.548 | 210.113 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -1.05031 | -0.90645 | -0.5308 | -0.35694 | -0.94912 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Atšķaidītā Normalizētā Peļņa par Akciju | -1.05031 | -0.90645 | -0.5308 | -0.35416 | -0.94912 |
Total Premiums Earned | 967.457 | 953.664 | 994.595 | 955.401 | 492.581 |
Net Investment Income | 27.674 | 25.524 | 22.652 | 17.945 | 3.545 |
Realized Gains (Losses) | -0.004 | -0.761 | 0.072 | -0.581 | -0.059 |
Losses, Benefits, and Adjustments, Total | 1070.01 | 1021.13 | 974.303 | 896.763 | 553.433 |
- Ikgadējs
- Ceturkšņa
2021 | 2020 | 2019 | |
---|---|---|---|
Nauda un Ekvivalenti | 1103.99 | 826.326 | 336.644 |
Debitoru Parādu Kopsumma, Neto | 40.659 | 31.157 | 25.122 |
Total Assets | 3321.65 | 2272.11 | 1346.91 |
Property/Plant/Equipment, Total - Net | 119.571 | 35.812 | 33.076 |
Property/Plant/Equipment, Total - Gross | 88.712 | 63.308 | 49.286 |
Accumulated Depreciation, Total | -42.101 | -27.496 | -16.21 |
Long Term Investments | 1431.56 | 692.127 | 363.228 |
Other Long Term Assets, Total | 28.68 | 26.971 | 25.505 |
Other Assets, Total | 458.769 | 594.391 | 533.271 |
Accounts Payable | 219.957 | 137.524 | 61.724 |
Notes Payable/Short Term Debt | 0 | 0 | 0 |
Total Liabilities | 1934.42 | 1823.09 | 996.308 |
Total Long Term Debt | 0 | 142.487 | 0 |
Long Term Debt | 0 | 142.487 | 0 |
Other Liabilities, Total | 0 | 15.005 | 8.819 |
Total Equity | 1387.23 | 449.018 | 350.606 |
Redeemable Preferred Stock | 0 | 1744.91 | 1295.74 |
Common Stock | 0.002 | 0.002 | 0.002 |
Additional Paid-In Capital | 3393.53 | 133.255 | 70.673 |
Retained Earnings (Accumulated Deficit) | -1999.71 | -1427.11 | -1012.86 |
Treasury Stock - Common | -2.923 | -2.923 | -2.923 |
Unrealized Gain (Loss) | -3.671 | 0.879 | -0.027 |
Total Liabilities & Shareholders’ Equity | 3321.65 | 2272.11 | 1346.91 |
Total Common Shares Outstanding | 210.013 | 197.037 | 197.037 |
Accrued Expenses | 91.67 | ||
Minority Interest | 5.293 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Nauda un Ekvivalenti | 2068.63 | 1103.99 | 1076.7 | 1671.54 | 2321.29 |
Debitoru Parādu Kopsumma, Neto | 50.615 | 40.659 | 43.099 | 39.917 | 37.765 |
Total Assets | 4350.52 | 3321.65 | 3169.88 | 3706.49 | 3594.36 |
Property/Plant/Equipment, Total - Net | 48.607 | 119.571 | 43.376 | 40.874 | 38.993 |
Long Term Investments | 1312.15 | 1431.56 | 1425.23 | 1418.27 | 718.613 |
Other Long Term Assets, Total | 27.793 | 28.68 | 28.242 | 26.922 | 26.934 |
Other Assets, Total | 685.425 | 458.769 | 435.703 | 423.336 | 374.913 |
Accounts Payable | 220.516 | 219.957 | 159.196 | 135.339 | 120.954 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 3018.48 | 1934.42 | 1616.67 | 1972.66 | 1808.12 |
Total Long Term Debt | 297.416 | 0 | 0 | 0 | 0 |
Long Term Debt | 297.416 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 77.058 | 0 | 0 | 0 | 0 |
Total Equity | 1332.04 | 1387.23 | 1553.21 | 1733.83 | 1786.24 |
Common Stock | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 |
Additional Paid-In Capital | 3422.03 | 3393.53 | 3356.41 | 3324.34 | 3303.03 |
Retained Earnings (Accumulated Deficit) | -2074.86 | -1999.71 | -1800.29 | -1587.55 | -1514.48 |
Treasury Stock - Common | -2.923 | -2.923 | -2.923 | -2.923 | -2.923 |
Unrealized Gain (Loss) | -12.206 | -3.671 | 0.017 | -0.04 | 0.604 |
Total Liabilities & Shareholders’ Equity | 4350.52 | 3321.65 | 3169.88 | 3706.49 | 3594.36 |
Total Common Shares Outstanding | 210.61 | 210.013 | 208.858 | 207.255 | 206.862 |
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Accrued Expenses | 91.67 | ||||
Minority Interest | 3.125 | 5.293 |
- Ikgadējs
- Ceturkšņa
2021 | 2020 | 2019 | |
---|---|---|---|
Neto ienākumi/Sākuma Līnija | -571.426 | -406.825 | -261.182 |
Nauda no Darbības | -181.745 | 222.732 | -165.37 |
Nauda no Darbības | 14.605 | 11.285 | 6.899 |
Deferred Taxes | -0.101 | -0.067 | -0.426 |
Bezskaidras Naudas Preces | 127.69 | 43.885 | 27.613 |
Izmaiņas Apgrozāmajā Kapitālā | 247.487 | 574.454 | 61.726 |
Nauda no Ieguldījumu Darbībām | -774.515 | -344.714 | 150.513 |
Kapitālie Izdevumi | -25.885 | -14.021 | -25.996 |
Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | -748.63 | -330.693 | 176.509 |
Nauda no Darbībām ar Finansēšanu | 1238.71 | 611.707 | -2.119 |
Naudas Plūsma Finansēšanas Posteņos | -15.211 | -4.84 | 0 |
Akciju Izsniegšana (Atkāpšanās), Neto | 1407.1 | 469.547 | -2.119 |
Parādu Izsniegšana (Atkāpšanās), Neto | -153.173 | 147 | 0 |
Neto Izmaiņas Naudā | 282.452 | 489.725 | -16.976 |
Cash Taxes Paid | 0.697 | ||
Samaksātie Procenti Naudā | 4.256 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -77.32 | -571.426 | -373.184 | -160.439 | -87.371 |
Cash From Operating Activities | 562.849 | -181.745 | -216.224 | 373.028 | 317.691 |
Cash From Operating Activities | 3.799 | 14.605 | 10.635 | 6.99 | 3.403 |
Deferred Taxes | 0 | -0.101 | 0.008 | 0.026 | 0.008 |
Non-Cash Items | 29.741 | 127.69 | 96.881 | 73.78 | 53.552 |
Cash Interest Paid | 0.261 | 4.256 | 3.994 | 3.742 | 3.553 |
Changes in Working Capital | 606.629 | 247.487 | 49.436 | 452.671 | 348.099 |
Cash From Investing Activities | 102.811 | -774.515 | -754.678 | -742.314 | -34.28 |
Capital Expenditures | -6.247 | -25.885 | -18.679 | -12.531 | -6.583 |
Other Investing Cash Flow Items, Total | 109.058 | -748.63 | -735.999 | -729.783 | -27.697 |
Cash From Financing Activities | 298.775 | 1238.71 | 1225.74 | 1214.54 | 1211.55 |
Financing Cash Flow Items | -6.785 | -15.211 | -22.441 | -22.441 | -22.441 |
Issuance (Retirement) of Stock, Net | 0.56 | 1407.1 | 1401.35 | 1390.15 | 1387.16 |
Issuance (Retirement) of Debt, Net | 305 | -153.173 | -153.173 | -153.173 | -153.173 |
Net Change in Cash | 964.435 | 282.452 | 254.837 | 845.252 | 1494.96 |
Cash Taxes Paid | 0.697 | 0.936 | 0.814 |
Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
---|---|---|---|---|---|---|
Alphabet, Inc. | Venture Capital | 13.2696 | 24042864 | 0 | 2022-12-31 | LOW |
Southeastern Asset Management, Inc. | Investment Advisor/Hedge Fund | 8.0452 | 14576904 | 3430032 | 2022-12-31 | LOW |
General Catalyst Partners | Venture Capital | 7.9834 | 14464995 | 0 | 2022-12-31 | LOW |
VK Services, LLC | Investment Advisor | 6.4602 | 11704997 | 0 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 6.3167 | 11445093 | 240020 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.064 | 9175358 | 2011461 | 2022-12-31 | LOW |
Formation8 GP, LLC | Investment Advisor | 4.0597 | 7355629 | 0 | 2021-09-30 | LOW |
Thrive Capital Management, LLC (NY) | Venture Capital | 2.6245 | 4755222 | 0 | 2022-12-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 2.2136 | 4010820 | 1320936 | 2022-12-31 | HIGH |
Lakestar (G.P.) Ltd | Investment Advisor/Hedge Fund | 1.7283 | 3131511 | 0 | 2022-09-30 | LOW |
Capital Research Global Investors | Investment Advisor | 1.5183 | 2751000 | 0 | 2022-12-31 | LOW |
Capital World Investors | Investment Advisor | 1.5183 | 2751000 | 0 | 2022-12-31 | LOW |
Millennium Management LLC | Hedge Fund | 1.4656 | 2655410 | 1086605 | 2022-12-31 | HIGH |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 1.4342 | 2598599 | 319220 | 2022-12-31 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 1.2062 | 2185523 | 1585624 | 2022-12-31 | LOW |
UBS Financial Services, Inc. | Investment Advisor | 1.1672 | 2114778 | 1216118 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.1644 | 2109804 | 121060 | 2022-12-31 | LOW |
Glynn Capital Management LLC | Investment Advisor/Hedge Fund | 1.0573 | 1915719 | 0 | 2022-12-31 | LOW |
Jacobs Levy Equity Management, Inc. | Investment Advisor/Hedge Fund | 0.9462 | 1714481 | 730302 | 2022-12-31 | MED |
Industry Ventures LLC | Private Equity | 0.9304 | 1685690 | 0 | 2022-12-31 | LOW |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com Group500K+
Tirgotāji
92K+
Ikmēneša aktīvie klienti
$53M+
Ikmēneša ieguldījumu apjoms
$30M+
Izņemts katru mēnesi
Treidinga kalkulators
Aprēķiniet iespējamo peļņu un zaudējumus, uzsākot CFD darījumu noteiktā dienā (izvēlaties datumu) un slēdzot darījumu citā dienā (izvēlaties datumu).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Oscar Health, Inc. Company profile
Par Oscar Health, Inc.
Oscar Health, Inc. ir veselības apdrošināšanas uzņēmums, kas ir izveidojis visaptverošu tehnoloģiju platformu, kas vērsta uz tās dalībnieku apkalpošanu. Uzņēmums galvenokārt piedāvā individuālos un ģimenes, mazo grupu un Medicare priekšrocību plānus, kā arī +Oscar platformu 607 apgabalos un 22 štatos. Tās individuālās un mazās grupas veido polises, ko privātpersonas un ģimenes iegādājas veselības apdrošināšanas tirgos. Tā piedāvā veselības plānus individuālajā tirgū biržā un ārpus biržas piecās metāla plānu kategorijās, piemēram, katastrofas, bronzas, sudraba, zelta un platīna. Tā piedāvā Medicare priekšrocību plānus pieaugušajiem, kuri ir 65 gadus veci un vecāki un kuriem ir tiesības uz tradicionālo Medicare. Tās +Oscar platforma nodrošina integrētus, visaptverošus veselības plānu pakalpojumus ar administratīvajiem veselības plāniem. Tās veselības plāni ietver piekļuvi ārstu un slimnīcu tīklam, kā arī personalizētu aprūpes komandu, kas atbalsta dalībniekus, sākot ar ārsta atrašanu un beidzot ar orientēšanos izmaksu jomā.
Industry: | Health Insurance |
75 Varick Street
5Th Floor
NEW YORK
NEW YORK 10013
US
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 500 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com